Skip to content
Search

Latest Stories

Submit Guest Post

Indian edtech firm Byju's averts insolvency

Byju’s agreed to settle a £14.8 million unpaid sponsorship debt owed to the country’s cricket board.

Indian edtech firm Byju's averts insolvency

An Indian appeals tribunal halted Insolvency proceedings against the educational technology firm Byju's on Friday.

The company agreed to settle a £14.8 million unpaid sponsorship debt owed to the country's cricket board.


Byju's, which gained popularity during the pandemic for its online learning products, faced financial challenges as students returned to classrooms. The company's valuation, once over £15 billion, has dropped significantly by an estimated 90 per cent.

Last month, a lower tribunal pushed Byju's into insolvency following the Board of Control for Cricket in India's (BCCI) claim of an unpaid debt of £14.8m for sponsoring Indian team jerseys during international matches.

Byju's appealed the National Company Law Tribunal's bankruptcy order and simultaneously worked out a settlement with the cricket board. On Friday, the National Company Law Appellate Tribunal (NCLAT) in Chennai approved the settlement and set aside the earlier order.

"In view of these facts, the settlement is hereby approved and the appeal succeeds and the impugned order is set aside," local media quoted the NCLAT as saying.

Byju's described the ruling as a "major victory" in a statement, saying its teams would "continue to work hard to strengthen stakeholder confidence and reinforce their commitment to serve millions of students."

(With inputs from AFP)

Add EasternEye As Your Trusted Source
preferred source on google news

More For You

Drug manufacturing

Novo Nordisk and AWS are bringing scientists and AI specialists together at a new London hub

iStock

Why Novo Nordisk is bringing Amazon deeper into its drug-making business

  • AWS will become Novo Nordisk's preferred cloud provider and strategic AI partner.
  • A new co-innovation hub at Novo Nordisk's King’s Cross facility will bring scientists and AWS engineers together.
  • More than 25,000 Novo Nordisk employees already use its AI tools.

Novo Nordisk is taking its use of AI in drug discovery a step further, joining forces with Amazon Web Services (AWS) to bring artificial intelligence deeper into the pharmaceutical giant's research, development and day-to-day operations.

Under the strategic partnership announced on August 10, AWS will become Novo Nordisk's preferred cloud provider and strategic AI partner. The companies are also setting up a co-innovation hub at Novo Nordisk's King’s Cross facility in London, where researchers, AI specialists, engineers and applied scientists will work together.

Keep ReadingShow less